led uk biobank licens deal
announc revenu street non-gaap ep
street manag maintain revenu guidanc increas ep
year post strong novaseq placement highest sinc launch
driven part uk biobank project management reiter expect us nh
project ramp continu believ posit well long-
term remain overweight pt unch ep cash
result report revenu street sequenc grew
array declin due dtc market overal
product revenu grew yoy street growth servic
revenu street includ one-tim liscens deal non-gaap
gross margin increas yoy street on-going oper margin
improv street lead ep street
busi deal updat post strongest quarter
placement novaseq nextseq believ place novaseq
impli placement given placement guidanc line
place multipl instrument uk biobank project
saw consum pullthrough larg popgen project
us nh ramp contribut revenu manag comment
trend custom upgrad larger instrument good long-term
put pressur consum near-term custom begin increas
util new instrument china flat normal stock
impact strong clinic use off-set deacceler research macro trend
pressur research budget uk releas provision find ilmn/
deal highlight anti-competit concern said believ
divestitur exit pacbio uk busi resolv concern
remedi see fit prohibit deal altogeth believ
find could reach across pond given sign memorandum understand
ftc march think deal break minim impact
believ pacbio fine given strong sequel ii launch
make final decis earli dec collect comment find
guidanc manag reiter revenu growth street
non-gaap ep prior street
stock believ well posit sequenc
market popgen project ramp thu remain overweight target
technolog develop competit product adopt govern fund
lead provid genet research technolog
price close octob
on-going ep
net cash-per-share
debt total capit
piper jaffray seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis report read conjunct import disclosur inform
includ attest regul analyst certif found page report follow site
page
thousand
updat
product revenu
sequenc
array
servic revenu
interest incom expens net
provis incom tax
revenu
product sale
sequenc
array
servic
good sold product sale
compani report piper jaffray co current disclosur inform compani locat
